Trademark: CSL VIFOR 2378989
Word
CSL VIFOR
ID
2378989
Trademark Type
WORD
Status
Protected: Registered/protected
Application Date
16 March 2023
Registration Date
16 March 2023
Renewal Date
16 March 2033

Service
Davies Collison Cave Pty Ltd

Goods and Services:
Class 5:
Pharmaceutical preparations and substances; blood plasma; blood products, included in this class; products derived from blood and products derived from recombinant DNA technology; vaccines; serums for medical use; antibodies; monoclonal antibodies; reagent red-blood cells; test kits, included in this class; diagnostic products, included in this class; blood products; medical and veterinary test kits; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and prevention of blood or bleeding disorders; blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums for medical use, namely, antivenom; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, in-vitro diagnostic reagent test kits for use in detecting cell-mediated immune response; pharmaceutical preparations and substances, namely, rhesus factor-D reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or immunoglobulin G subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical or clinical use for the typing and detection of specific blood cells, and the detection of relevant complement components and immunoglobulin subtypes; pharmaceutical or veterinary preparations for use in oncology and diabetes; pharmaceutical or veterinary preparations for use in transplantation, transplantation rejection therapy and transplantation-associated diseases and conditions; pharmaceutical or veterinary preparations comprising stem cells; pharmaceutical or veterinary preparations for use in dialysis-associated diseases, conditions and complications; pharmaceutical or veterinary preparations for use in preserving or improving renal function, for the treatment or prevention of acute kidney injury, for the treatment or prevention of chronic kidney diseases and associated complications; pharmaceutical or veterinary preparations for the treatment or prevention of cardiac, cardiovascular, circulatory, renal system, kidney, cardio-renal, immune system, gastroenterological, gastrointestinal, stomach, dermatological, hematological, bone, respiratory, genetic, allergic, inflammation, infectious, pain, central nervous system, endocrinology, hormonal, muscular, rheumatic, ocular and metabolic diseases and disorders; pharmaceutical and veterinary preparations used as immune system stimulators; pharmaceutical preparations for the treatment or prevention of mineral deficiencies or mineral overload as well as diseases and conditions associated with mineral deficiencies or mineral overload; pharmaceutical preparations for the treatment or prevention of metal deficiencies or metal overload as well as diseases and conditions associated with metal deficiencies or metal overload; pharmaceutical preparations for the treatment or prevention of vitamin deficiencies or vitamin overload as well as diseases and conditions associated with vitamin deficiencies or vitamin overload, vitamin and mineral supplements, vitamin preparations and mineral preparations for medical use; sanitary products for medical purposes; dietetic foods for medical or veterinary use; food for babies; food supplements for humans and animals; medical plasters, medical dressings; material for dental fillings and dental impressions; disinfectants.